Long-term use of hydroxyurea for sickle cell anemia.
作者信息
Hagar Ward
出版信息
JAMA. 2003 Aug 13;290(6):753; author reply 754. doi: 10.1001/jama.290.6.753-a.
PMID:12915424
Abstract
摘要
相似文献
1
Long-term use of hydroxyurea for sickle cell anemia.羟基脲用于镰状细胞贫血的长期治疗。
JAMA. 2003 Aug 13;290(6):753; author reply 754. doi: 10.1001/jama.290.6.753-a.
2
Hydroxyurea and sickle cell disease: a chance for every patient.羟基脲与镰状细胞病：给每位患者的机遇。
JAMA. 2003 Apr 2;289(13):1692-4. doi: 10.1001/jama.289.13.1692.
3
Hydroxyurea for sickle cell anemia.羟基脲用于镰状细胞贫血。
N Engl J Med. 2008 Jul 3;359(1):98; author reply 98-9. doi: 10.1056/NEJMc080902.
4
Hydroxycarbamide for sickle-cell anaemia in infancy.羟基脲用于婴儿镰状细胞贫血
Lancet. 2011 May 14;377(9778):1628-30. doi: 10.1016/S0140-6736(11)60511-4.
5
Hydroxyurea, sickle cell disease and renal transplantation.羟基脲、镰状细胞病与肾移植
Nephron. 1997;75(1):106-7. doi: 10.1159/000189511.
6
Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy.接受羟基脲治疗的镰状细胞贫血患儿胎儿血红蛋白反应的预测因素。
Blood. 2002 Jan 1;99(1):10-4. doi: 10.1182/blood.v99.1.10.
7
[From Hemoglobin SS to SF: interest of hydroxyurea in the management of sickle cell disease in two Congolese children and review of the literature].[从血红蛋白SS到SF：羟基脲在两名刚果儿童镰状细胞病管理中的作用及文献综述]
Pan Afr Med J. 2015 Jun 15;21:124. doi: 10.11604/pamj.2015.21.124.5784. eCollection 2015.
8
Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease.羟基脲在2至5岁镰状细胞病患儿中的应用。
J Pediatr Hematol Oncol. 2000 Jul-Aug;22(4):330-4. doi: 10.1097/00043426-200007000-00009.
9
Early detection of response to hydroxyurea therapy in patients with sickle cell anemia.镰状细胞贫血患者对羟基脲治疗反应的早期检测。
Hemoglobin. 2010;34(5):424-9. doi: 10.3109/03630269.2010.513638.
10
Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.新型治疗镰状细胞病的方法：组蛋白去乙酰化酶抑制剂的潜力。
Expert Rev Hematol. 2012 Jun;5(3):303-11. doi: 10.1586/ehm.12.20.
Zotero 插件